T-cell recognition of alloantigen involves both the MHC molecule and i
ts associated peptide ligand. To understand the relationship between t
he specificity of alloantigen recognition and the structure of TCR mol
ecules, we have investigated TCR gene utilization by sequencing TCR ge
nes from a well-defined allospecific T-lymphocyte clones. Alloreactive
TLC consisted of a panel of clones primed to recognize DR1-related al
loantigens. Our sequencing results revealed rxcensiuely diverse, but n
onrandom, usage of TCR AV and BV gene segments and essentially no cons
ervation in CDR3 or junctional sequences. Such observations are consis
tent with allospecific TCR that interact with MHC molecules on a gener
ic level while recognizing specific peptides. They also reduce potenti
al enthusiasm for anti-TCR therapy in allograft rejection.